Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Longschade COVID-19 berekenen met AI-software
mrt 2021 | Pneumonie, Virale infecties